Drug development has countless examples of compounds that looked promising in animals but failed in humansor worse, caused harm
So in that 25 years, using frameworks like the phenotypes that you've actually studied, how much success were you able to have with lifestyle-focused treatments
In characterization work it was described as the first selective secretagogue, stimulating growth-hormone release in pituitary-cell and animal models without significantly elevating ACTH, cortisol, or prolactin above baseline
This therapy is often sought out by individuals dealing with chronic inflammation, slow recovery from injuries or surgery, and persistent joint pain
Plasma, urine, and hair specimens for each patient were collected on the same day prior to surgery